Table 4.
Follow-Up Serum Complement Concentrations Between the Non-Remission and Remission Groups
| Persistent Non-Remission Group (n=16) | Follow-Up Remission Group (n=19) | P | |
|---|---|---|---|
| Follow-up proteinuria (g/24 h) | 5.02 (2.68–7.29) | 0.31 (0.23–0.45) | 0.001 |
| Follow-up albumin (g/l) | 28.05 (21.60–35.03) | 42.10 (36.90–44.00) | 0.001 |
| Follow-up serum creatinine (umol/L) | 106.70 (74.50–177.30) | 73.95 (63.75–103.80) | 0.012 |
| Follow-up eGFR (mL/(min*1.72m2)) | 64.01 (26.15–91.80) | 91.24 (71.32–108.05) | 0.030 |
| Follow-up serum IgG (mg/dl) | 495.50 (359.25–615.50) | 701.00 (504.00–1231.50) | 0.089 |
| Follow-up serum IgA (mg/dl) | 151.00 (65.80–239.25) | 341.00 (131.00–381.50) | 0.128 |
| Follow-up serum IgM (mg/dl) | 55.75 (32.45–68.60) | 74.40 (60.55–190.05) | 0.002 |
| Follow-up serum C3 (mg/dl) | 88.30 (74.50–97.00) | 99.10 (84.20–111.25) | 0.044 |
| Follow-up serum C4 (mg/dl) | 24.20 (20.90–29.35) | 21.00 (15.85–37.05) | 0.731 |
| Follow-up serum C1q (mg/dl) | 156.00 (130.75–193.00) | 205.00 (147.50–275.50) | 0.088 |
Notes: Non-normally distributed variables were presented as median (25–75% interquartile range [IQR]). Bold: having significant difference with p < 0.05.
Abbreviation: eGFR, estimated glomerular filtration rate.